Furthermore, considering the recent evidence suggesting that the blood level of PGRMC1 is a potent marker for breast cancer prognosis [26], our study also shows the possibility of using Pgrmc1 as a survival expectancy marker in patients with breast cancer. The gene discussed is PGRMC1; the disease is breast carcinoma.